Atlas Trials

Apomorphine Effects on Pain in Parkinson's Disease

Clinical trial NCT04879134 · UNKNOWN

Trial details

NCT number
NCT04879134
Sponsor
University of Calgary
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2022-02-28
Primary completion
2023-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.